Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

ilding; 10:00 AM * House Small Business subcommittee hybrid hearing on `Preventing Fraud and Abuse of PPP and EIDL' - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on `Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government Accountability

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

lding; 10:00 AM • House Small Business subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government Accountability

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ing; 10:00 AM • House Small Business subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL' - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government Accountability

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ing; 10:00 AM • House Small Business subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL' - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on EFTA01658535 'Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government